BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10544870)

  • 1. The FSGS factor: enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma.
    Brouhard BH
    Clin Pediatr (Phila); 1999 Oct; 38(10):615-6. PubMed ID: 10544870
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.
    McCarthy ET; Sharma M; Savin VJ
    Clin J Am Soc Nephrol; 2010 Nov; 5(11):2115-21. PubMed ID: 20966123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FSGS permeability factor-associated nephrotic syndrome: remission after oral galactose therapy.
    De Smet E; Rioux JP; Ammann H; Déziel C; Quérin S
    Nephrol Dial Transplant; 2009 Sep; 24(9):2938-40. PubMed ID: 19509024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLE and idiopathic nephrotic syndrome: coincidence or not?
    Hertig A; Droz D; Lesavre P; Grünfeld JP; Rieu P
    Am J Kidney Dis; 2002 Dec; 40(6):1179-84. PubMed ID: 12460036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal vein thrombosis, nephrotic syndrome, and focal lupus glomerulonephritis.
    Gutierrez Millet V; Usera G; Alcazar de la Ossa JM; Ruilope LM; Ortuno MT; Rodicio JL
    Br Med J; 1978 Jan; 1(6104):24-5. PubMed ID: 620135
    [No Abstract]   [Full Text] [Related]  

  • 6. Depletion of clusterin in renal diseases causing nephrotic syndrome.
    Ghiggeri GM; Bruschi M; Candiano G; Rastaldi MP; Scolari F; Passerini P; Musante L; Pertica N; Caridi G; Ferrario F; Perfumo F; Ponticelli C
    Kidney Int; 2002 Dec; 62(6):2184-94. PubMed ID: 12427144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple Myeloma in a Patient with Focal Segmental Glomerulosclerosis: A Case Report.
    Oweis AO; Al Shelleh SA; Aldaoud N; Alshari OM; Al-Abbadi MA
    Am J Case Rep; 2018 Aug; 19():946-950. PubMed ID: 30100602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence of focal segmental glomerulosclerosis after kidney transplantation: strategies and outcome.
    Ulinski T
    Curr Opin Organ Transplant; 2010 Oct; 15(5):628-32. PubMed ID: 20733489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular podocyte vacuolation in focal segmental glomerulosclerosis.
    Yoshikawa N; Ito H; Akamatsu R; Hazikano H; Okada S; Matsuo T
    Arch Pathol Lab Med; 1986 May; 110(5):394-8. PubMed ID: 3754422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cyclosporin A in the therapy of nephrotic syndrome caused by focal-segmental glomerulosclerosis].
    Jovanović D; Kovacević Z; Rabrenović V
    Vojnosanit Pregl; 2000; 57(3):303-7. PubMed ID: 11039311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors of venous thromboembolism in focal segmental glomerulosclerosis with nephrotic syndrome.
    Li SJ; Tu YM; Zhou CS; Zhang LH; Liu ZH
    Clin Exp Nephrol; 2016 Apr; 20(2):212-7. PubMed ID: 26220221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B infection as a possible cause of focal segmental glomerulosclerosis (FSGS).
    Herberth J; Herberth Z; Abul-Ezz SR; Kumar J; Gokden N
    Clin Nephrol; 2006 May; 65(5):380-4. PubMed ID: 16724663
    [No Abstract]   [Full Text] [Related]  

  • 13. The long-term results of pediatric patients with primary focal and segmental glomerulosclerosis.
    Sozeri B; Mir S; Mutlubas F; Sen S
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):87-92. PubMed ID: 20061699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS).
    Canaud G; Dion D; Zuber J; Gubler MC; Sberro R; Thervet E; Snanoudj R; Charbit M; Salomon R; Martinez F; Legendre C; Noel LH; Niaudet P
    Nephrol Dial Transplant; 2010 Apr; 25(4):1321-8. PubMed ID: 19773419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of endothelial dysfunction in patients with primary focal segmental glomerulosclerosis.
    Zhang Q; Zeng C; Fu Y; Cheng Z; Zhang J; Liu Z
    Nephrology (Carlton); 2012 May; 17(4):338-45. PubMed ID: 22295953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
    Markowitz GS; Schwimmer JA; Stokes MB; Nasr S; Seigle RL; Valeri AM; D'Agati VD
    Kidney Int; 2003 Oct; 64(4):1232-40. PubMed ID: 12969141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of plasma fractions from patients with focal and segmental glomerulosclerosis on rat proteinuria.
    Le Berre L; Godfrin Y; Lafond-Puyet L; Perretto S; Le Carrer D; Bouhours JF; Soulillou JP; Dantal J
    Kidney Int; 2000 Dec; 58(6):2502-11. PubMed ID: 11115084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [No effect of rituximab in pediatric case of severe nephrotic syndrome and focal segmental glomeruloslerosis accompanied by renal insufficiency].
    Hyla-Klekot L; Grenda R; Pulcer B
    Pol Merkur Lekarski; 2008 Dec; 25(150):519-22. PubMed ID: 19205386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nephrotic syndrome.
    Hricik DE; Kassirer JP
    Dis Mon; 1982 Apr; 28(7):1-56. PubMed ID: 6917785
    [No Abstract]   [Full Text] [Related]  

  • 20. CD80, suPAR and nephrotic syndrome in a case of NPHS2 mutation.
    Cara-Fuentes G; Araya C; Wei C; Rivard C; Ishimoto T; Reiser J; Johnson RJ; Garin EH
    Nefrologia; 2013; 33(5):727-31. PubMed ID: 24089165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.